Study shows how immune cells change wiring of the developing mouse brain

May 23, 2012

Researchers have shown in mice how immune cells in the brain target and remove unused connections between brain cells during normal development. This research, supported by the National Institutes of Health, sheds light on how brain activity influences brain development, and highlights the newly found importance of the immune system in how the brain is wired, as well as how the brain forms new connections throughout life in response to change.

Disease-fighting cells in the brain, known as microglia, can prune the billions of tiny connections (or synapses) between neurons, the brain cells that transmit information through electric and chemical signals. This new research demonstrates that microglia respond to neuronal activity to select synapses to prune, and shows how this pruning relies on an pathway – the complement system – to eliminate synapses in the way that bacterial cells or other pathogenic debris are eliminated. The study was led by Beth Stevens, Ph.D., assistant professor of neurology at Boston Children's Hospital and Harvard Medical School.

The brain is created with many more synapses than it retains into adulthood. As the brain develops, it goes through dynamic changes to refine its circuitry, trimming away the synaptic connections that do not have a lot of activity, and preserving the stronger, more active synapses. This period, known as synaptic pruning, is a key part of normal brain development.

Scientists do not have a clear understanding of how these synapses are selected, targeted and then pruned. However, precise elimination of unused synapses and strengthening those that are most needed is essential for normal brain function. Many childhood disorders, such as amblyopia (a loss of vision in one eye that can occur when the eyes are misaligned), various forms of mental retardation, epilepsy and autism are thought to be due to abnormal brain development.

Microglia originate in the bone marrow and transform into an activated state to defend the body against infections. Activated microglia are also found in other disease states, ranging from stroke to Alzheimer's disease. It is not always clear, however, if these cells cause degeneration of , or if they are part of the brain's recovery process. In more recent years, several research groups reported that activated microglia are also present in the normal brain. Additionally, during the most robust synaptic pruning periods there is an increased number of activated microglia present and clustered around synapses.

As reported in the May 24 issue of Neuron, scientists in Dr. Stevens's lab used the visual system in to study synaptic pruning, a model that undergoes robust change and remodeling during development and which has circuitry that is well-defined and easy to manipulate. Researchers labeled neurons that project from the eye into an area of the brain called the lateral geniculate nucleus, or LGN, and found that reactive microglia contained portions of the synapses from the labeled neurons. They also saw that these labeled pieces of synaptic material were specifically found inside the microglia's lysosomes – compartments responsible for digesting foreign particles.

The researchers then investigated if the amount of at a synapse determines whether microglia target it for removal. They used a drug to increase activity in the neurons projecting from one eye and saw less pruning of synapses in the corresponding brain region, as compared to the untreated eye. When they used a drug to reduce activity, this resulted in more pruning compared to the untreated eye. The researchers think microglia select a synapse for removal based on the synapse's level of activity. This may be directly relevant to amblyopia, a loss of vision in one eye that can occur when the eyes are misaligned. Children with amblyopia will preferentially use one eye and vision in the less used eye deteriorates due loss of synapses and cells in the LGN.

Earlier research revealed that proteins involved in the complement system are found near synapses during development and are necessary for pruning. To see if these same proteins are used by microglia to shape neuronal connections, the researchers disrupted complement pathway proteins that are found only in the brain's . Their results indicate that these complement proteins signal the microglia to trim away synapses, and suggest that pathways are key to proper synaptic pruning.

"The concept that microglia prune using immune system pathways has been difficult to prove," said Edmund Talley, Ph.D., program director at the National Institute of Neurological Disorders and Stroke, "This exquisitely careful and meticulous research confirms the role of microglia in , plasticity and learning."

Dr. Stevens said the study sheds light on the role of microglia in the normal brain, and supports further investigations into the role of microglia in brain disease. "Almost every neurodegenerative disease involves several interesting common denominators," she said. "It's becoming increasingly recognized that early synapse loss is a hallmark of many neurodegenerative diseases."

Explore further: Gardening in the brain: Specialist cells prune connections between neurons

More information: Schafer, D. et al. "Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner" Neuron, May 24, 2012.

Related Stories

Gardening in the brain: Specialist cells prune connections between neurons

July 21, 2011
Gardeners know that some trees require regular pruning: some of their branches have to be cut so that others can grow stronger. The same is true of the developing brain: cells called microglia prune the connections between ...

Researchers uncover steps in synapse building, pruning

November 16, 2011
Like a gardener who stakes some plants and weeds out others, the brain is constantly building networks of synapses, while pruning out redundant or unneeded synapses. Researchers at The Jackson Laboratory led by Assistant ...

The Japanese traditional therapy, honokiol, blocks key protein in inflammatory brain damage

March 19, 2012
Microglia are the first line defence of the brain and are constantly looking for infections to fight off. Overactive microglia can cause uncontrolled inflammation within the brain, which can in turn lead to neuronal damage. ...

Recommended for you

Brain recovery longer than clinical recovery among athletes following concussion, research suggests

August 24, 2017
University athletes with a recent concussion had changes in their brain structure and function even after they received medical clearance to return to play, a new study has found.

Exercising immediately after study may help you remember

August 24, 2017
Exercise may be the secret to retaining information, according to new research from UNSW that may encourage more physical activity in classrooms and nursing homes.

Scientists discover common obesity and diabetes drug reduces rise in brain pressure

August 23, 2017
Research led by the University of Birmingham, published today in Science Translational Medicine, has discovered that a drug commonly used to treat patients with either obesity or Type II diabetes could be used as a novel ...

Use of brain-computer interface, virtual avatar could help people with gait disabilities

August 23, 2017
Researchers from the University of Houston have shown for the first time that the use of a brain-computer interface augmented with a virtual walking avatar can control gait, suggesting the protocol may help patients recover ...

Researcher working to develop new tool for non-invasive neuromodulation of human brain

August 23, 2017
A UTA researcher is developing a technology that will map and image the effects of infrared light shone on the human brain that may be able to modulate and improve brain waves and circuits at certain spots in the brain.

Physicist reports binary marker of preclinical and clinical Alzheimer's disease

August 23, 2017
A new technique shows high potential for providing a discrete, non-invasive biomarker of Alzheimer's disease (AD) at the individual level during both preclinical and clinical stages. The proposed biomarker has a large effect ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.